Latest Breaking News On - Commercialize ryzneuta - Page 1 : comparemela.com

Evive Biotech has entered into a license agreement with Acrotech Biopharma, a New Jersey-based and wholly-owned subsidiary of Aurobindo Pharma USA Inc., to commercialize Ryzneuta™ i.e., Efbemalenograstim alfa in the US.

United statesAshish anvekarSimon liAcrotech biopharmaYifan pharmaceutical coAurobindo pharmaAurobindo pharma united states incEvive enters license agreementCommercialize ryzneutaYifan pharmaceuticalNew jersey basedBiologics license applicationMarketing authorization applicationNew drug applicationAurobindo pharma limited